KDM4C and leukemia: These results are in line with the dispensable embryonic function of Kdm4c for development into phenotypically normal Kdm4c knockout mouse (Pedersen et al., 2014), suggesting a potential therapeutic window for targeting Kdm4c for leukemia suppression.